New hope for NF1 patients: experimental drug targets painful nerve tumors
Disease control
Recruiting now
This phase 2 trial tests an oral drug called HLX-1502 in people aged 12 and older with neurofibromatosis type 1 (NF1) who have plexiform neurofibromas—nerve tumors that can cause pain, disfigurement, or other problems. The study will enroll 25 participants and measure whether the…
Phase: PHASE2 • Sponsor: Healx Limited • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC